How do we know it was B12 deficiency
1 and 2)
Mechanism and Side Effects of IGF-1 LR3 Aug 12022 IGF-1 LR3 is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1).It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence ("arginine 3"), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) ("long"), for a total of 83 amino acids (relative to the 70 of IGF-1).The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability

Conventional Joint Treatment Pain medications that mask symptoms Cortisone injections that provide temporary relief Physical therapy alone without addressing tissue damage Eventual recommendation for joint replacement surgery No coordination with broader health conditions Single-modality approach within one specialty Joint Therapy at PMC Regenerative treatments that activate the body's own tissue repair Advanced diagnostics to identify root causes of degeneration Complementary therapies (prolozone, HBOT, IV) to optimize healing Non-surgical approach with minimal downtime Whole-person care that addresses inflammation, nutrition, and hormones Full integrative team across multiple medical disciplines under one roof Therapies That Support Joint Healing Ozone / Prolozone Therapy One of the primary regenerative injection therapies used for joint conditions at PMC
Most follicles take 2-4 months to produce a visible hair once activated
The drug activates THR, a nuclear hormone receptor predominantly expressed in the liver and acts as a key regulator of metabolic pathways in this organ